Yu S - Search Results

1

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.

Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: yu s. J Hematol Oncol. 2014 Dec 5;7:87. doi: 10.1186/s13045-014-0087-z. J Hematol Oncol. 2014. PMID: 25477004 Free PMC article. Review.

2

[Gefitinib in the treatment of advanced non-small-cell lung cancer].

Zhang L, Yu SY. Zhang L, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):539-41. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147123 Clinical Trial. Chinese.

3

Astrocytes facilitate the growth and differentiation of co-cultured mesenchymal stem cells.

Chu Q, Yu Z, Zhang S, Yu S. Chu Q, et al. Among authors: yu s, yu z. J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):333-6. doi: 10.1007/s11596-008-0323-2. Epub 2008 Jun 19. J Huazhong Univ Sci Technolog Med Sci. 2008. PMID: 18563335

4

[Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].

Zhang MX, Han N, Yu SY, Leng Y. Zhang MX, et al. Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):325-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953828 Chinese.

5

The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.

Wu H, Deng J, Yu S, Wang X, Chen Y. Wu H, et al. Among authors: yu s. J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):108-12. doi: 10.1007/s11596-010-0120-6. Epub 2010 Feb 14. J Huazhong Univ Sci Technolog Med Sci. 2010. PMID: 20155466

6

Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.

Zhang L, Yuan X, Chen Y, Du XJ, Yu S, Yang M. Zhang L, et al. Among authors: yu s. Gene. 2013 Mar 15;517(1):60-4. doi: 10.1016/j.gene.2012.12.087. Epub 2013 Jan 9. Gene. 2013. PMID: 23313300

7

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.

Huang Y, Chen Y, Mei Q, Chen Y, Yu S, Xia S. Huang Y, et al. Among authors: yu s. Oncol Rep. 2013 Jun;29(6):2486-92. doi: 10.3892/or.2013.2357. Epub 2013 Mar 22. Oncol Rep. 2013. PMID: 23525575

8

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.

Zou M, Xia S, Zhuang L, Han N, Chu Q, Chao T, Peng P, Chen Y, Gui Q, Yu S. Zou M, et al. Among authors: yu s. Int J Oncol. 2013 Jun;42(6):2094-102. doi: 10.3892/ijo.2013.1895. Epub 2013 Apr 12. Int J Oncol. 2013. PMID: 23588221

9

The presence of EGFR mutations predicts the response in Chinese non-small cell lung cancer patients treated with erlotinib.

Li RC, Zheng LJ, Fang MH, Yu SY. Li RC, et al. Int J Biol Markers. 2014 Jun 25;29(2):e112-9. doi: 10.5301/jbm.5000059. Int J Biol Markers. 2014. PMID: 24425324 Free article.

10

miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.

Chang BP, Wang DS, Xing JW, Yang SH, Chu Q, Yu SY. Chang BP, et al. J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):201-206. doi: 10.1007/s11596-014-1259-3. Epub 2014 Apr 8. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 24710933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,584 results

Search Page

Filters